Quantitative Structure − Activity Relationship Models of Clinical Pharmacokinetics : Clearance and Volume of Distribution

Reliable prediction of two fundamental human pharmacokinetic (PK) parameters, systemic clearance (CL) and apparent volume of distribution (Vd), determine the size and frequency of drug dosing and are at the heart of drug discovery and development. Traditionally, estimated CL and Vd are derived from preclinical in vitro and in vivo absorption, distribution, metabolism, and excretion (ADME) measurements. In this paper, we report quantitative structure-activity relationship (QSAR) models for prediction of systemic CL and steady-state Vd (Vdss) from intravenous (iv) dosing in humans. These QSAR models avoid uncertainty associated with preclinical-to-clinical extrapolation and require two-dimensional structure drawing as the sole input. The clean, uniform training sets for these models were derived from the compilation published by Obach et al. (Drug Metab. Disp. 2008, 36, 1385-1405). Models for CL and Vdss were developed using both a support vector regression (SVR) method and a multiple linear regression (MLR) method. The SVR models employ a minimum of 2048-bit fingerprints developed in-house as structure quantifiers. The MLR models, on the other hand, are based on information-rich electro-topological states of two-atom fragments as descriptors and afford reverse QSAR (RQSAR) analysis to help model-guided, in silico modulation of structures for desired CL and Vdss. The capability of the models to predict iv CL and Vdss with acceptable accuracy was established by randomly splitting data into training and test sets. On average, for both CL and Vdss, 75% of test compounds were predicted within 2.5-fold of the value observed and 90% of test compounds were within 5.0-fold of the value observed. The performance of the final models developed from 525 compounds for CL and 569 compounds for Vdss was evaluated on an external set of 56 compounds. The predictions were either better or comparable to those predicted by other in silico models reported in the literature. To demonstrate the practical application of the RQSAR approach, the structure of vildagliptin, a high-CL and a high-Vdss compound, is modified based on the atomic contributions to its predicted CL and Vdss to propose compounds with lower CL and lower Vdss.

[1]  Patricia Ruiz,et al.  Assessing the toxic effects of ethylene glycol ethers using Quantitative Structure Toxicity Relationship models. , 2011, Toxicology and applied pharmacology.

[2]  Kiyomi Ito,et al.  Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches , 2004, Pharmaceutical Research.

[3]  A. Hossain,et al.  A comparative study on detection of influential observations in linear regression , 1991 .

[4]  Franco Lombardo,et al.  In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set. , 2009, Journal of medicinal chemistry.

[5]  Franco Lombardo,et al.  In silico Prediction of Total Human Plasma Clearance , 2012, J. Chem. Inf. Model..

[6]  Abdelmonem A. Afifi,et al.  Comparison of Stopping Rules in Forward Stepwise Discriminant Analysis , 1979 .

[7]  John G. Topliss,et al.  QSAR Model for Drug Human Oral Bioavailability1 , 2000 .

[8]  Patrick Poulin,et al.  Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. , 2002, Journal of pharmaceutical sciences.

[9]  Shawn Martin,et al.  Lattice Enumeration for Inverse Molecular Design Using the Signature Descriptor , 2012, J. Chem. Inf. Model..

[10]  Melvin J. Yu.  Predicting Total Clearance in Humans from Chemical Structure , 2010, J. Chem. Inf. Model..

[11]  Gary W. Caldwell,et al.  Allometric scaling of pharmacokinetic parameters in drug discovery: Can human CL, Vss and t1/2 be predicted fromin-vivo rat data? , 2004, European Journal of Drug Metabolism and Pharmacokinetics.

[12]  D J Rance,et al.  The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. , 1997, The Journal of pharmacology and experimental therapeutics.

[13]  Peter J. Rousseeuw,et al.  Robust Regression and Outlier Detection , 2005, Wiley Series in Probability and Statistics.

[14]  Ulf Norinder,et al.  Prediction of ADMET Properties , 2006, ChemMedChem.

[15]  Bill J Smith,et al.  Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches , 2009, Journal of clinical pharmacology.

[16]  Mark T. D. Cronin,et al.  A Hierarchical QSAR Model for Urinary Excretion of Drugs in Humans as a Predictive Tool for Biotransformation , 2003 .

[17]  J. Topliss,et al.  QSAR model for drug human oral bioavailability. , 2000, Journal of medicinal chemistry.

[18]  Ovidiu Ivanciuc,et al.  Applications of Support Vector Machines in Chemistry , 2007 .

[19]  U. Norinder,et al.  Computational approaches to the prediction of the blood-brain distribution. , 2002, Advanced drug delivery reviews.

[20]  Lawrence X. Yu,et al.  Predicting Human Oral Bioavailability of a Compound: Development of a Novel Quantitative Structure-Bioavailability Relationship , 2000, Pharmaceutical Research.

[21]  Vijay K Gombar,et al.  Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability. , 2003, Current topics in medicinal chemistry.

[22]  Joseph V. Turner,et al.  Bioavailability Prediction Based on Molecular Structure for a Diverse Series of Drugs , 2004, Pharmaceutical Research.

[23]  Yoshitaka Yano,et al.  Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis. , 2002, Journal of pharmaceutical sciences.

[24]  Franco Lombardo,et al.  Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds , 2008, Drug Metabolism and Disposition.

[25]  Miklos Feher,et al.  Rapid Prediction of Human Intestinal Absorption , 2002 .

[26]  Adriano D Andricopulo,et al.  Hologram QSAR model for the prediction of human oral bioavailability. , 2007, Bioorganic & medicinal chemistry.

[27]  John Mandel,et al.  The Regression Analysis of Collinear Data. , 1986, Journal of research of the National Bureau of Standards.

[28]  Jianling Wang,et al.  The impact of early ADME profiling on drug discovery and development strategy , 2004 .

[29]  J. Mandel.  Use of the Singular Value Decomposition in Regression Analysis , 1982 .

[30]  Mauricio Leal,et al.  Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species , 2007, Drug Metabolism and Disposition.

[31]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.